Imaging cellular proliferation as a measure of response to therapy

Journal of Clinical Pharmacology

Volumn 41, Issue 7 SUPPL., 2001, Pages

  Krohn, K A ^a   Mankoff, D A ^a   Eary, J F ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; FLUOROURACIL; NUCLEOTIDE; RADIOPHARMACEUTICAL AGENT; THYMIDINE; TRACER; DIAGNOSTIC AGENT;

BLOOD BRAIN BARRIER; CANCER THERAPY; CATABOLISM; CELL DEATH; CELL GROWTH; CELL LABELING; CELL PROLIFERATION; CELL TRANSPORT; CELL VIABILITY; CONFERENCE PAPER; DIAGNOSTIC IMAGING; DNA SYNTHESIS; DOCUMENTATION; IMAGE ANALYSIS; IMMUNE RESPONSE; POSITRON EMISSION TOMOGRAPHY; TUMOR LOCALIZATION; TUMOR VOLUME; VALIDATION PROCESS; ANIMAL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; HUMAN; IMAGE PROCESSING; NEOPLASM; REVIEW; SCINTISCANNING;

ANIMALS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; NEOPLASMS; RADIOPHARMACEUTICALS; THYMIDINE; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0034743498     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1177/009127001773744215     Document Type: Conference Paper

References (55)

1. Nuclear medicine in oncology diagnosis
2. Can positron emission tomography (PET) be used to detect subclinical response to cancer therapy?
3. Cell proliferation
4. The significance of residual mediastinal abnormality on the chest radiograph following treatment for Hodgkin's disease
5. Pathological assessment of response to induction chemotherapy in breast cancer
6. The clinical applications of cell kinetics in cancer therapy
7. Biologic markers as predictors of clinical outcome from systemic therapy for primary operable breast cancer
8. Thymidine metabolism and cell kinetics
9. In vitro determination of thymidine-[H-3] labeling index in human solid tumors
10. Detection of DNA synthesis in intact organisms with positron-emitting methyl-[C-11]-thymidine
11. 11C labeled thymidine for tumor visualization using positron emission tomography
12. 11C]-thymidine for quantification of cellular proliferation with PET
13. Alternatives in the synthesis of 2-[C-11]-thymidine
14. High performance liquid chromatography of carbon-11 labeled thymidine and its major catabolites for clinical PET studies
15. Measurement of [methyl-carbon-11] thymidine and its metabolites in head and neck tumors
16. [Methyl-carbon-11] thymidine for in vivo measurement of cell proliferation
17. Analysis of 2-carbon-11-thymidine metabolites in PET imaging
18. Contribution of labeled carbon dioxide to PET imaging of carbon-11-labeled compounds
19. 2 into the acid-labile, the acid-soluble, the lipid, the protein and the nucleic acid fractions of rat brain tissue
20. [C-11]-Carbon dioxide fixation and equilibration in rat brain: Effects on acid-base measurements
21. Utilization of labeled thymidine in DNA synthesis: Studies for PET
22. Kinetic analysis of 2-[carbon-11]-thymidine PET imaging studies: Compartmental model and mathematical analysis
23. Positron imaging feasibility studies: I. Characteristics of [H-3]-thymidine uptake in rodent and canine neoplasms: Concise communication
24. Short-term uptake in normal and neoplastic tissues: Studies for PET
25. Tumor and organ biochemical profiles in vivo following uptake of a combination of radiolabeled substrates: A potential application for PET
26. The relationship of thymidine metabolism to the use of fractional incorporation as a measure of DNA synthesis in tissue proliferation
27. In vitro assessment of 2-fluoro-2-deoxy-D-glucose, L-methionine and thymidine as agents to monitor the early response of a human adenocarcinoma cell line to radiotherapy
28. 3H]thymidine, and gallium-67
29. A model for compartmentation of de novo and salvage thymidine nucleotide pools in mammalian cells
30. Cellular sources of thymidine nucleotides: Studies for PET
31. In vivo measurement of carbon-11 thymidine uptake in non-Hodgkin's lymphoma using positron emission tomography
32. 11C-thymidine activity in human head and neck tumors using positron emission tomography (PET)
33. 11C]thymidine PET imaging studies: Validation studies
34. A graphical analysis method to estimate blood-tissue transfer constants for systems with labeled metabolites
35. Use of spectral analysis to obtain images from dynamic PET studies
36. Monitoring response to treatment in the development of anti-cancer drugs using positron emission tomography (PET)
37. Spectral analysis of dynamic PET studies
38. Imaging radiotracer model parameters in PET: A mixture analysis approach
39. 2-[C-11]Thymidine imaging of malignant brain tumors
40. 11C]thymidine in patients with squamous cell carcinoma of the head and neck
41. 11C]-thymidine positron emission tomography in tumoral and non-tumoral cerebral lesions
42. Carbon-11-thymidine and FDG to measure therapy response
43. Tumor metabolism and proliferation using quantitative PET imaging in renal cell carcinoma patients treated with IL-2
44. 124I]-iodo-2′-deoxyuridine for functional PET imaging of cell proliferation
45. In vitro and animal validation of bromine-76-bromodeoxyuridine as a proliferation marker
46. Imaging of brain tumor proliferative activity with iodine-131-iododeoxyuridine
47. Radiosynthesis of labeled β-pseudothymidine ([C-11]- and [H-3]-methyl) and its biodistribution and metabolism in normal and tumored mice
48. Development of labeled thymidine analogs for imaging tumor proliferation
49. Distribution, metabolism, and excretion of I-(2-fluoro-2-deoxy-β-D-arabinofuranosyl) and 1-(2- fluoro-2-deoxy-β-D-arabinofuranosyl)-5-iodocytosine
50. 11C]-FMAU): A potential nucleoside analog for in vivo study of cellular proliferation with PET
51. Synthesis of [F-18]-2-fluoro-5-methyl-1-β-D-arabinofuranosyluracil (EF-18]FMAU)
52. Relationship between plasma concentrations of 3′-deoxy-3′-fluorothymidine (alovudine) and antiretroviral activity in two concentration-controlled trials
53. 18F]FLT for imaging of cellular proliferation in vivo
54. Diverging substrate specificity of pure human thymidine kinases 1 and 2 against antiviral dideoxynucleosides
55. Imaging proliferation in vivo with [F-18]-FLT and positron emission tomography